March 01, 2015 2:36 AM ET


Company Overview of Adaptive Therapeutics, Inc.

Executive Profile

Muzammil M. Mansuri Ph.D.

Executive Chairman, Adaptive Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships


Dr. Muzammil M. Mansuri, Ph.D. served as the Chief Executive Officer and Executive Chairman of CGI Pharmaceuticals, Inc. (formerly, Cellular Genomics Inc.). Dr. Mansuri served as Senior Advisor for JSB-Partners, LP, having joined it in January 2006. He serves as President and Chief Executive Officer of BIKAM Pharmaceuticals. He is a Partner at Gilliam Capital and an Advisor to JSB Partners. He joined Flagship in 2002. He served as the Chairman and Acting Chief Executive ...

Corporate Headquarters

5820 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-909-9050
Fax: 858-909-0958

Board Members Memberships

Chairman of the Board and Chief Executive Officer
Former Director
Former Director
Executive Chairman


University College London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adaptive Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at